Literature DB >> 35836463

Incidental Finding of Appendiceal Mucinous Neoplasm After Trauma: A Case Report.

Rebecca Odom1, Keelin F Roche1, Bracken Burns1.   

Abstract

Appendiceal neoplasms are uncommon; most are identified by pathologic examination after appendectomy for presumed appendicitis or as an incidental finding. When found incidentally, patients are typically asymptomatic. If the neoplasm has perforated, patients may present with symptoms that mimic acute appendicitis. In advanced disease, patients may have systemic symptoms associated with peritoneal disease, including abdominal distension, weight loss, and diffuse abdominal pain. Because of their rarity, as well as rapidly evolving research on the subject, the nomenclature of appendiceal mucinous neoplasms has proven challenging. This lesion was identified as a low-grade appendiceal mucinous neoplasm (LAMN), previously termed mucoceles or mucinous cystadenomas. LAMNs are non-invasive neoplasms that have the potential to proliferate outside the appendix in a malignant fashion. All mucinous appendiceal neoplasms can perforate and spread mucin production throughout the abdominal cavity, known as pseudomyxoma peritonei (PMP). The presence of PMP designates LAMNs as malignant, though the neoplasm itself is non-invasive. When appendiceal neoplasms have peritoneal involvement, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is the standard of care. Complete cytoreduction has been shown to be an independent predictor of survival. Here we describe a case of a 30-year-old male involved in a motor vehicle collision with a grade IV splenic laceration, who is also found to have a large appendiceal mass. His traumatic injuries required emergent intervention, which delayed treatment of his malignancy.
Copyright © 2022, Odom et al.

Entities:  

Keywords:  appendiceal mucinous neoplasm; appendix injury; cytoreductive surgery; peritoneal carcinomatosis index; splenic laceration

Year:  2022        PMID: 35836463      PMCID: PMC9273193          DOI: 10.7759/cureus.25832

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Incidental findings are common in trauma patients that undergo whole-body computed tomography (CT) scans. Studies on patients receiving whole-body CT scans found incidental findings in 35-50% of patients [1,2]. However, traumatic injuries can complicate the timing and treatment course for an incidentally discovered disease. Here we describe a case of a 30-year-old male involved in a motor vehicle collision who was found to have a large appendiceal mass. He required emergent treatment for a high-grade splenic laceration, which altered and delayed the treatment course of his appendiceal neoplasm. Ultimately, the patient received cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for his low-grade appendiceal mucinous neoplasm and is now disease-free and undergoing monitoring for recurrence. Had this not been found during his traumatic injury it is unknown if he would have received timely treatment for this deadly disease.

Case presentation

A previously healthy 30-year-old male presented to the emergency department after being involved in a motor vehicle collision. Exam and subsequent CT imaging revealed a grade 4 splenic laceration, as well as fractures of the left 6th, 8th, 9th, and 10th ribs, and a chip fracture of the left olecranon. Incidentally, the tip of the appendix was also noted to have a 5.6 x 4.9 cm, peripherally calcified, low-density lesion (Figure 1).
Figure 1

CT demonstrating 5.6 x 4.9 centimeter mass at the tip of the appendix.

The patient was hemodynamically stable and was taken from the trauma bay to the radiology suite for angioembolization of the proximal splenic artery. Post-procedure, he was admitted to the Intensive Care Unit (ICU) for serial hemoglobin and cardiac monitoring. His hemoglobin trended down slightly from 12.1 to 9.9 g/dL over the course of three days. During this period, a discussion was held with the patient and family by the trauma team regarding his incidental appendiceal lesion - imaging characteristics were consistent with a mucinous neoplasm, though, without a tissue diagnosis, the malignant potential was unknown. He denied having any symptoms prior to admission, any family history of cancer, or ever having a colonoscopy. Seven days after his initial injury when the patient was fully recovered from his splenic embolization and his pain well-controlled from his rib fractures, he was prepared for surgical exploration. At a minimum, the size of the lesion warranted a partial right colectomy. However, this lesion was concerning for a mucinous neoplasm; if mucin were present in the abdomen, he would require hyperthermic intraperitoneal chemotherapy (HIPEC), which would require transfer to a cancer center. The abdomen was entered using the Veress needle technique, and upon inserting the laparoscope into the abdomen, we identified mucin-like material spread throughout the abdomen (Figure 2).
Figure 2

Intraoperative image demonstrating mucinous deposit in the peritoneal cavity.

The sequelae of his splenic injury were also noted, with pooling of coagulated blood throughout the abdomen. Additional laparoscopic ports were placed to aid in collecting specimens for pathology. A peritoneal biopsy was obtained for permanent pathology, a sample of mucinous-appearing peritoneal fluid was sent for cytology, and the operation was concluded. Microscopic examination of the peritoneum revealed fibroadipose tissue with reactive mesothelial cells, interstitial mucin, and microcalcifications without evidence of neoplastic cells or overt malignancy. Few atypical epithelioid cells were noted on cytology. Tumor markers obtained prior to surgery demonstrated CA 125 of 23 U/mL (normal 0-35 U/mL), CA 19-9 12 U/mL (normal 0-37 U/mL), CEA 7.2 ng/mL (normal 0-2.5 ng/mL). Post-operatively, the patient was referred to a facility with HIPEC capabilities due to our finding of pseudomyxoma peritonei. His procedure was postponed for four months to allow for recovery from his polytraumatic injuries and delays related to the COVID-19 pandemic. Prior to surgery, he underwent a colonoscopy in which two tubular adenomas and two hyperplastic polyps were removed; no abnormalities were noted at the appendiceal orifice. The patient then proceeded with exploratory laparotomy with the intent of cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, and a partial right colectomy. Prior to surgery, cystoscopy and bilateral ureteral stent placement were performed. A midline laparotomy incision was made, and upon entering the abdominal cavity, mucinous deposits were encountered throughout the abdomen - on the surface of the right liver, small bowel mesentery, wall of the anterior rectum, the surface of the terminal ileum, and peritoneum of the right upper quadrant, right lower quadrant, and right mid-abdomen. The peritoneal carcinomatosis index (PCI) score was 13. The appendix was dilated, and the tip had perforated. A total omentectomy was then performed, followed by resection of the right-sided peritoneum. Mucinous nodules of the liver and anterior rectum were removed bluntly, and nodules of the small bowel mesentery were removed by a combination of sharp dissection and Argon beam. A right partial colectomy with ileocolonic anastomosis was performed, as well as a cholecystectomy. HIPEC was then performed in a standard fashion. No visible disease was noted; the complete cytoreduction (CCR) score was 0. The abdomen was then closed, and surgery was concluded. The final pathology report revealed a low-grade mucinous neoplasm of the appendix with no invasive component. No further surgical treatment will be necessary at this time. He will undergo continued monitoring through the cancer center.

Discussion

Appendiceal neoplasms are uncommon; they represent less than 1% of all gastrointestinal malignant neoplasms [3]. They are most often identified by pathologic examination after appendectomy for presumed appendicitis or as an incidental finding. When found incidentally, patients are typically asymptomatic. If the neoplasm has perforated, patients may present with symptoms that mimic acute appendicitis. In advanced disease, patients may have systemic symptoms associated with peritoneal disease, including abdominal distension, weight loss, and diffuse abdominal pain. Because of their rarity, as well as rapidly evolving research on the subject, the nomenclature of appendiceal mucinous neoplasms has proven challenging. The Peritoneal Surface Oncology Group International (PSOGI) and American Joint Committee on Cancer (AJCC) have only just recently developed guidelines for a more simplified classification of appendiceal neoplasms [4,5]. Epithelial neoplasms are defined as mucinous or nonmucinous; nonmucinous appendiceal adenomas and adenocarcinomas are treated in a pathway identical to similar colon neoplasms [5]. Mucinous neoplasms are further subdivided into non-invasive and invasive neoplasms. Low-grade appendiceal mucinous neoplasms (LAMNs) are non-invasive neoplasms that have the potential to proliferate outside the appendix in a malignant fashion. These lesions were previously termed mucoceles or mucinous cystadenomas, but these terms have fallen out of use. All mucinous appendiceal neoplasms, both invasive and non-invasive, have the propensity to perforate and spread mucin production throughout the abdominal cavity, known as pseudomyxoma peritonei (PMP) [6,7]. Though LAMNs are indolent, the presence of PMP should be considered malignant, as the disease is now considered disseminated. When appendiceal neoplasms have peritoneal involvement, cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is now considered the standard of care [3,4,8,9]. The Sugarbaker’s Peritoneal Carcinomatosis Index (PCI) is calculated intra-operatively based on the size, location, and number of the tumor deposits and provides an objective measurement of the extent of disease [3]. However, this scoring system has not yet been correlated with survival in cases of complete cytoreduction. Complete cytoreduction, defined as the resection of all visible disease, has been shown to be an independent predictor of survival [3,8,9]. Multiple studies have indicated that patients who undergo CRS-HIPEC for both low-grade and high-grade PMP demonstrate longer patient survival, decrease tumor recurrence, and longer disease-free intervals compared to patients that undergo cytoreductive surgery alone or palliative systemic chemotherapy [8,9]. Systemic chemotherapy has not been shown to be of any benefit to patients with the low-grade disease [2,3].

Conclusions

Incidental findings are very common in trauma patients and vary tremendously in their clinical significance. This case highlights an incidentally found rare malignancy in a trauma patient. Although his injuries delayed the treatment of the malignancy, the trauma facilitated the diagnosis and without it, it is unknown if he would have been diagnosed in a timely manner. His care was furthered by excellent communication between a rural trauma center and a quaternary care cancer center which allowed him to undergo a lifesaving cancer operation within four months of sustaining his trauma. This case highlights the importance of diligence and a high index of suspicion with incidental findings in trauma which can allow a trauma surgeon to save a patient’s life well beyond the realm of acute injuries.
  9 in total

1.  Incidental CT findings in trauma patients: incidence and implications for care of the injured.

Authors:  Thomas R Paluska; Michael J Sise; Daniel I Sack; C Beth Sise; Michael C Egan; Michael Biondi
Journal:  J Trauma       Date:  2007-01

2.  The American Society of Colon and Rectal Surgeons, Clinical Practice Guidelines for the Management of Appendiceal Neoplasms.

Authors:  Sean C Glasgow; Wolfgang Gaertner; David Stewart; Jennifer Davids; Karim Alavi; Ian M Paquette; Scott R Steele; Daniel L Feingold
Journal:  Dis Colon Rectum       Date:  2019-12       Impact factor: 4.585

3.  Incidental findings on total-body CT scans in trauma patients.

Authors:  J C Sierink; T P Saltzherr; M J A M Russchen; S M M de Castro; L F M Beenen; N W L Schep; J C Goslings
Journal:  Injury       Date:  2013-10-30       Impact factor: 2.586

4.  The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms.

Authors: 
Journal:  Ann Surg Oncol       Date:  2020-04-13       Impact factor: 5.344

5.  Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.

Authors:  Patrick L Wagner; Frances Austin; Ugwuji Maduekwe; Arun Mavanur; Lekshmi Ramalingam; Heather L Jones; Matthew P Holtzman; Steven A Ahrendt; Amer H Zureikat; James F Pingpank; Herbert J Zeh; David L Bartlett; Haroon A Choudry
Journal:  Ann Surg Oncol       Date:  2013-03-02       Impact factor: 5.344

6.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

7.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Authors:  B M Ronnett; C M Zahn; R J Kurman; M E Kass; P H Sugarbaker; B M Shmookler
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

8.  8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Sjoerd Bruin; Henk Boot; Gooike van Slooten; Harm van Tinteren
Journal:  Ann Surg Oncol       Date:  2008-06-03       Impact factor: 5.344

Review 9.  An Update on the Diagnosis, Grading, and Staging of Appendiceal Mucinous Neoplasms.

Authors:  Mark A Valasek; Reetesh K Pai
Journal:  Adv Anat Pathol       Date:  2018-01       Impact factor: 3.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.